Table I.
Gene name | Chromosome | HPV status | Mean β | SD | Ratio of HPV positive vs. HPV negative | P-value | Methylation |
---|---|---|---|---|---|---|---|
C14orf162/CCDC177 | 14 | Positive | 0.161 | 0.041 | 0.579 | 0.019a | Hypo |
Negative | 0.278 | 0.034 | |||||
CDH8 | 4 | Positive | 0.479 | 0.062 | 1.640 | 0.004a | Hyper |
Negative | 0.292 | 0.055 | |||||
CRMP1 | 4 | Positive | 0.208 | 0.058 | 1.155 | 0.749 | Hyper |
Negative | 0.180 | 0.058 | |||||
ELMO1 | 7 | Positive | 0.578 | 0.067 | 1.234 | 0.026a | Hyper |
Negative | 0.468 | 0.033 | |||||
HTR1E | 6 | Positive | 0.433 | 0.062 | 1.357 | 0.027a | Hyper |
Negative | 0.319 | 0.060 | |||||
MEI1 | 22 | Positive | 0.318 | 0.072 | 0.849 | 0.008a | Hypo |
Negative | 0.531 | 0.087 | |||||
MSX2 | 5 | Positive | 0.394 | 0.081 | 2.213 | 0.009a | Hyper |
Negative | 0.178 | 0.065 | |||||
PCDH10 | 4 | Positive | 0.333 | 0.103 | 1.524 | 0.166 | Hyper |
Negative | 0.220 | 0.023 | |||||
PCDHB11 | 5 | Positive | 0.548 | 0.074 | 1.302 | 0.042a | Hyper |
Negative | 0.421 | 0.076 | |||||
PITX2 | 4 | Positive | 0.416 | 0.112 | 1.386 | 0.138 | Hyper |
Negative | 0.300 | 0.088 | |||||
SYN2 | 3 | Positive | 0.399 | 0.115 | 1.013 | 0.781 | Hyper |
Negative | 0.394 | 0.104 |
P<0.05, indicates a statistically significant difference. Cohort of 8 samples (4 HPV+HNSCC, 4 HPV-HNSCC). HNSCC, head and neck squamous cell carcinoma; HPV, human papilloma virus; chrom, chromosome; SD, standard deviation; meth, methylation status; hypo, hypomethylated; hyper, hypermethylated; C14orf162/CCDC177; chromosome 14 open reading frame 162/coiled-coil domain containing 177; CDH8, cadherin 8; CRMP1, collapsin response mediator protein 1; ELMO1, engulfment and cell motility 1; HTR1E, 5-hydroxytryptamine receptor 1E; MEI1, meiotic double-stranded break formation protein 1; MSX2, msh homeobox 2; PCDH10, protocadherin 10; PCDHB11, protocadherin β-11; PITX2, paired like homeodomain 2; SYN2, synapsin II.